| Literature DB >> 34923775 |
Zhongqin Chen1, Jintao Zhou1, Dengchang Wu1, Caihong Ji1, Benyan Luo1, Kang Wang1.
Abstract
OBJECTIVE: The goal of this study was to examine whether the static functional connectivity (FC) of the executive control network (ECN) and the temporal properties of dynamic FC states in the ECN can characterize the underlying nature of anti-N-methyl-d-aspartate (anti-NMDA) receptor encephalitis and their correlations with cognitive functions.Entities:
Mesh:
Year: 2021 PMID: 34923775 PMCID: PMC8791804 DOI: 10.1002/acn3.51487
Source DB: PubMed Journal: Ann Clin Transl Neurol ISSN: 2328-9503 Impact factor: 4.511
Demographic and clinical data of patients.
| Patient | Sex | Age | Igg NMDA receptor antibodies (CSF titre) | Symptoms | Hospital stay, (months) | mRS Score | Time between initial discharge and data acquisition (months) | ||
|---|---|---|---|---|---|---|---|---|---|
| Initial | Total | Before treatment | At study time point | ||||||
| 1 | F | 24 | 1:32 | Behaviour | LOC, dyskinesia, seizure, behaviour, cognition | 1.2 | 5 | 0 | 18.5 |
| 2 | F | 22 | 1:32 | Behaviour, seizure | LOC, dyskinesia, seizure, behaviour, cognition | 1.1 | 5 | 0 | 6.5 |
| 3 | M | 28 | 1:32 | Behaviour, dyskinesia | LOC, dyskinesia, seizure, behaviour, cognition, autonomic instability | 1.2 | 5 | 1 | 9.3 |
| 4 | M | 31 | 1:32 | Seizure, LOC | LOC, dyskinesia, seizure, behaviour, cognition, autonomic instability | 1.4 | 5 | 0 | 21 |
| 5 | F | 15 | 1:32 | Dyskinesia, seizure | Dyskinesia, seizure, behaviour, cognition | 1.2 | 4 | 1 | 6.1 |
| 6 | F | 25 | 1:32 | Behaviour, seizure | LOC, dyskinesia, seizures, behaviour, cognition | 1.2 | 5 | 0 | 8.3 |
| 8 | F | 16 | 1:10 | Behaviour | Seizure, behaviour, cognition | 1.2 | 4 | 0 | 10.6 |
| 9 | F | 29 | 1:3.2 | Behaviour | LOC, behaviour, cognition | 0.7 | 4 | 0 | 6.5 |
| 10 | 48 | 1:32 | Behaviour, seizure | Seizure, behaviour, cognition | 1.1 | 4 | 1 | 8.5 | |
| 11 | F | 33 | 1:10 | dyskinesia, Cognition | Dyskinesia, behaviour, cognition | 0.9 | 4 | 0 | 12.1 |
| 12 | F | 18 | 1:32 | Behaviour | dyskinesia, seizure, behaviour, cognition | 1.3 | 4 | 0 | 6.7 |
| 13 | F | 18 | 1:32 | Behaviour, LOC | LOC, dyskinesia, seizure, behaviour, cognition | 0.9 | 5 | 1 | 13.3 |
| 14 | M | 19 | 1:10 | Seizure, behaviour | LOC, dyskinesia, seizure, behaviour, cognition | 2.1 | 5 | 1 | 10.3 |
| 15 | F | 40 | 1:10 | Seizure, behaviour | Seizure, behaviour, cognition | 0.8 | 4 | 1 | 7.2 |
| 16 | M | 22 | 1:32 | Behaviour | LOC, dyskinesia, seizures, behaviour, cognition | 0.8 | 4 | 0 | 23.9 |
| 17 | F | 41 | 1:10 | Seizure, behaviour | LOC, seizure, behaviour, cognition, autonomic instability | 1.2 | 5 | 1 | 16 |
| 18 | F | 34 | 1:32 | Behaviour, cognition | LOC, dyskinesia, seizures, behaviour, cognition, autonomic instability | 26 | 5 | 0 | 36.2 |
| 19 | F | 24 | 1:32 | Seizure, behaviour, | Seizure, behaviour, cognition | 1.3 | 5 | 0 | 23.2 |
| 20 | M | 21 | 1:32 | Behaviour, seizure | LOC, seizure, behaviour, cognition | 1.3 | 4 | 0 | 21.5 |
| 21 | M | 44 | 1:10 | Behaviour | Seizure, behaviour, cognition | 1.2 | 4 | 1 | 11.2 |
| 22 | M | 25 | 1:32 | Behaviour, seizure | LOC, dyskinesia, seizures, behaviour, cognition, autonomic instability | 1.6 | 5 | 0 | 47 |
CSF, cerebrospinal fluid; LOC, loss of consciousness; mRS, modified Rankin scale; NMDA, N‐methyl‐d‐aspartate.
Figure 1The five independent components of executive control network identified by a group ICA. IC 3, mainly located in the ventrolateral prefrontal cortex; IC 15, mainly located in the dorsolateral and medial prefrontal cortex; IC 19 and 27, mainly located in the right frontoparietal executive network; IC 29, mainly located in the left frontoparietal executive network; ICA, independent component analysis.
Results of cognitive tests of patients and healthy controls.
| Item | HCs (mean ± SD) | Patients (mean ± SD) |
|
|
|---|---|---|---|---|
| Age (years) | 26.43 ± 5.22 | 27.48 ± 9.49 | 0.445 | 0.659 |
| Education (years) | 14.65 ± 1.77 | 13.52 ± 2.34 | 1.79 | 0.081 |
| SDMT | 59.26 ± 7.57 | 47.81 ± 10.13 | 4.27 | 0.000 |
| DST (forward) | 9.30 ± 0.97 | 8.33 ± 1.74 | 2.31 | 0.026 |
| DST (backward) | 7.48 ± 1.31 | 5.57 ± 1.43 | 4.61 | 0.000 |
| Stroop test (colour dot) | 12.72 ± 2.04 | 14.44 ± 2.73 | −2.44 | 0.019 |
| Stroop test (colour word) | 24.27 ± 5.96 | 31.07 ± 1.26 | −2.33 | 0.025 |
|
| 14.04 ± 0.82 | 12.29 ± 2.57 | 3.11 | 0.003 |
|
| 13.83 ± 1.03 | 11.90 ± 2.53 | 3.36 | 0.002 |
|
| 14.87 ± ````0.34 | 14.43 ± 0.93 | 2.13 | 0.039 |
| SAS | 22.09 ± 2.54 | 23.33 ± 2.85 | −1.53 | 0.133 |
| SDS | 21.91 ± 3.18 | 22.61 ± 2.58 | −0.81 | 0.425 |
DST, Digit Span Test; HCs, healthy controls; SAS, Self‐Rating Anxiety Scale; SDMT, Symbol‐Digit Modalities Test; SDS, Self‐Rating Depression Scale; CAVLT, Chinese auditory verbal learning test.
p < 0.05/8 (Bonferroni correction).
p < 0.05 (uncorrected results).
Results of static functional connectivity among independent components of ECN.
| Functional connectivity |
|
|
|---|---|---|
| IC 3‐IC 15 | −0.1151 | 0.9089 |
| IC 3‐IC 19 | 0.0049 | 0.9961 |
| IC 3‐IC 27 | 0.5391 | 0.5926 |
| IC 3‐IC 29 | 1.534 | 0.1325 |
| IC 15‐IC 19 | −0.5958 | 0.5545 |
| IC 15‐IC 27 | 3.0567 | 0.0039 |
| IC 15‐IC 29 | 3.2336 | 0.0024 |
| IC 19‐IC 27 | −0.7767 | 0.4417 |
| IC 19‐IC 29 | 0.2891 | 0.7739 |
| IC 27‐IC 29 | 2.5718 | 0.0137 |
ECN, executive control network; IC 15, mainly located in the dorsolateral and medial prefrontal cortex; IC 19 and 27, mainly located in the right frontoparietal executive network; IC 29, mainly located in the left frontoparietal executive network; IC 3, mainly located in the ventrolateral prefrontal cortex.
p < 0.05 (FDR corrected).
p < 0.05 (FDR uncorrected).
Figure 2Results of functional connectivity among independent components of ECN. ECN, executive control network; HCs, healthy controls; IC 15, mainly located in the dorsolateral and medial prefrontal cortex; IC 27, mainly located in the right frontoparietal executive network; IC 29, mainly located in the left frontoparietal executive network. *p < 0.05 (FDR corrected).
Figure 3Significant correlations between functional connectivity of two independent components and individual cognitive performance in patients with anti‐NMDA receptor encephalitis. (A) symbol‐digit modalities test (DST). (B) symbol‐digit modalities test (SDMT). IC 15, mainly located in dorsolateral and medial prefrontal cortex; IC 27, mainly located in right fronto‐parietal executive network; IC 29, mainly in left fronto‐parietal executive network.
Figure 4Results of the clustering analysis per state. The total number of occurrences and percentage of total occurrences are listed above each cluster median. IC 3, mainly located in the ventrolateral prefrontal cortex; IC 15, mainly located in the dorsolateral and medial prefrontal cortex; IC 19 and 27, mainly located in the right frontoparietal executive network; IC 29, mainly located in the left frontoparietal executive network.
Results of functional connectivity in each state among independent components of ECN.
| Functional connectivity | IC 15‐IC 27 | IC 15‐IC 29 | ||
|---|---|---|---|---|
|
|
|
|
| |
| State 1 | −1.17 | 0.2486 | −2.50 | 0.0167 |
| State 2 | −2.89 | 0.0062 | −1.40 | 0.1687 |
| State 3 | −3.42 | 0.0015 | −2.46 | 0.0186 |
| State 4 | −0.84 | 0.4041 | −0.25 | 0.8014 |
ECN, executive control network; FDR, false discovery rate; IC 15 = mainly located in the dorsolateral and medial prefrontal cortex, IC 27 = mainly located in the right frontoparietal executive network, IC 29 = mainly located in the left frontoparietal executive network.
p < 0.05 (FDR corrected).
p < 0.05 (FDR uncorrected).
Figure 5Temporal properties of dynamic functional connectivity states for the anti‐NMDA receptor encephalitis and healthy control groups. (A) Mean dwell time. (B) the fractional windows were plotted using violin plots. Horizontal lines indicate group medians and interquartile range (solid and dashed line, respectively). HCs = healthy controls. *p < 0.05.
Figure 6Significant correlations between fractional windows in State 1 and individual performance of DST (A), Stroop test (B) in patients with anti‐NMDA receptor encephalitis. DST, digit span test; anti‐NMDA, anti‐N‐methyl‐d‐aspartate.